Curcuma longa as a Natural Immunomodulator for Preventing infection from COVID 19 With an In Silico Approach
DOI:
10.29303/jbt.v22i2.3281Published:
2022-03-10Downloads
Abstract
SARS-CoV-2 is a Coronaviridae virus with a single-stranded RNA genome. This virus is highly contagious and spreads rapidly, with mutations occurring at a rapid pace. Various preventive actions have been implemented to prevent the spread of Covid-19 instances. The World Health Organization recommended that everyone clean their hands, masks, and other items in their environment on a frequent basis. As a result of these measures, the virus's transmission will be slowed. Furthermore, keeping one's immune system is critical for limiting the spread of Covid-19. As a result of a weakening immune system, our body's defenses will deteriorate, making us more susceptible to sickness and unable to fight diseases caused by viruses or bacteria. If the immune system is strong, it will recognize and kill viral and bacterial compounds when they are exposed. Immunomodulators, such as natural vitamins and herbs, can help maintain and boost immunity. Indonesia is primarily a farming country. In Indonesia, many different varieties of plants can be grown. Turmeric is an Indonesian medicinal plant that may be found all across the country. Turmeric's ability to act as an immunomodulator has also been proven. As a result, the goal of this study is to determine the usefulness of the active chemicals found in the Curcuma longa plant as a natural immunomodulator in order to avoid mutations of the COVID 19 variation by looking at the background of the current situation. The approach employed in this study is an in silico Molecular Docking test, with the goal of determining the active side of the drug and the value of Binding Affinity from the Docking data. Tissue Pharmacology is used to depict the protein network found in turmeric plants, as well as the substances and diseases that are linked to these proteins. According to the findings, the compound quercetin acts as a ligand for the PIK3CG protein and has a high binding affinity of -7.4. As a result, it can be identified as a substance that acts as a natural immunomodulator in turmeric plants.
References
Bhat, S. A., Rather, S. A., Iqbal, A., Qureshi, H. A., & Islam, N. (2020). Immunomodulators for Curtailing COVID-19: a Positive Approach. Journal of Drug Delivery and Therapeutics, 10(3-s), 286ââ¬â294. https://doi.org/10.22270/jddt.v10i3-s.4085
Datta, N., Pal, M., Roy, U., Mitra, R., & Pradhan, A. (2014). IMMUNOSTIMULANT DRUGS IN UNANI MEDICINE Abdul. Infection, 13(6), 15. https://doi.org/10.20959/wjpr20206-17643
Fakhmi, K. E., Kusumaningtyas, N., & Priyatama, E. (n.d.). DOCKING MOLEKULAR POTENSI ANTI DIABETES MELITUS TIPE 2 TURUNAN ZERUMBON SEBAGAI INHIBITOR ALDOSA REDUKTASE DENGAN AUTODOCK-VINA.
http://journal.unpad.ac.id/jcena/article/view/10443/4759
Gigliobianco, M. R., Casadidio, C., Censi, R., & di Martino, P. (2018). Nanocrystals of poorly soluble drugs: Drug bioavailability and physicochemical stability. In Pharmaceutics (Vol. 10, Issue 3). MDPI AG. https://doi.org/10.3390/pharmaceutics10030134
J, K., D, C., & M, R. (2019). Molecular Docking, Drug-likeness Studies and ADMET Prediction of Quinoline Imines for Antimalarial Activity. Journal of Medicinal Chemistry and Drug Design, 2(1). https://doi.org/10.16966/2578-9589.113
Nopiyanto, Y. E., Raibowo, S., Sugihartono, T., & Yarmani, Y. (2020). Pola Hidup Sehat Dengan Olahraga dan Asupan Gizi Untuk Meningkatkan Imun Tubuh Menghadapi Covid-19. Dharma Raflesia : Jurnal Ilmiah Pengembangan Dan Penerapan IPTEKS, 18(2), 90ââ¬â100. https://doi.org/10.33369/dr.v18i2.13008
Nugraha, S. P. (2015). Pelatihan Penanaman Tanaman Obat Keluarga (Toga). Asian Journal of Innovation and Entrepreneurship, 4(Vol 4, No 01 (2015): January 2015), 58ââ¬â62.
https://journal.uii.ac.id/ajie/article/viewFile/7896/6905
Prasetio, N. F., Bodhi, W., Manampiring, A., & Budiarso, F. (2021). eISSN 2337-330X eBiomedik. 9(1), 101ââ¬â106. https://doi.org/10.35790/ebm.9.1.2021.31809
License
Copyright (c) 2022 Lely Mauliana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
